Warning

 

Close

Confirm Action

Are you sure you wish to do this?

Confirm Cancel
BCM
User Panel

Site Notices
Posted: 9/29/2022 8:00:31 AM EDT
Outcomes at least 90 days since onset of myocarditis after mRNA COVID-19 vaccination in adolescents and young adults in the USA: a follow-up surveillance study

https://www.thelancet.com/journals/lanchi/article/PIIS2352-4642(22)00244-9/fulltext#gr3

Background
Data on medium-term outcomes in indivduals with myocarditis after mRNA COVID-19 vaccination are scarce. We aimed to assess clinical outcomes and quality of life at least 90 days since onset of myocarditis after mRNA COVID-19 vaccination in adolescents and young adults.

Methods
In this follow-up surveillance study, we conducted surveys in US individuals aged 12–29 years with myocarditis after mRNA COVID-19 vaccination, for whom a report had been filed to the Vaccine Adverse Event Reporting System between Jan 12 and Nov 5, 2021. A two-component survey was administered, one component to patients (or parents or guardians) and one component to health-care providers, to assess patient outcomes at least 90 days since myocarditis onset. Data collected were recovery status, cardiac testing, and functional status, and EuroQol health-related quality-of-life measures (dichotomised as no problems or any problems), and a weighted quality-of-life measure, ranging from 0 to 1 (full health). The EuroQol results were compared with published results in US populations (aged 18–24 years) from before and early on in the COVID-19 pandemic.

Findings
Between Aug 24, 2021, and Jan 12, 2022, we collected data for 519 (62%) of 836 eligible patients who were at least 90 days post-myocarditis onset: 126 patients via patient survey only, 162 patients via health-care provider survey only, and 231 patients via both surveys. Median patient age was 17 years (IQR 15–22); 457 (88%) patients were male and 61 (12%) were female. 320 (81%) of 393 patients with a health-care provider assessment were considered recovered from myocarditis by their health-care provider, although at the last health-care provider follow-up, 104 (26%) of 393 patients were prescribed daily medication related to myocarditis. Of 249 individuals who completed the quality-of-life portion of the patient survey, four (2%) reported problems with self-care, 13 (5%) with mobility, 49 (20%) with performing usual activities, 74 (30%) with pain, and 114 (46%) with depression. Mean weighted quality-of-life measure (0·91 [SD 0·13]) was similar to a pre-pandemic US population value (0·92 [0·13]) and significantly higher than an early pandemic US population value (0·75 [0·28]; p<0·0001). Most patients had improvements in cardiac diagnostic marker and testing data at follow-up, including normal or back-to-baseline troponin concentrations (181 [91%] of 200 patients with available data), echocardiograms (262 [94%] of 279 patients), electrocardiograms (240 [77%] of 311 patients), exercise stress testing (94 [90%] of 104 patients), and ambulatory rhythm monitoring (86 [90%] of 96 patients). An abnormality was noted among 81 (54%) of 151 patients with follow-up cardiac MRI; however, evidence of myocarditis suggested by the presence of both late gadolinium enhancement and oedema on cardiac MRI was uncommon (20 [13%] of 151 patients). At follow-up, most patients were cleared for all physical activity (268 [68%] of 393 patients).

Interpretation
After at least 90 days since onset of myocarditis after mRNA COVID-19 vaccination, most individuals in our cohort were considered recovered by health-care providers, and quality of life measures were comparable to those in pre-pandemic and early pandemic populations of a similar age. These findings might not be generalisable given the small sample size and further follow-up is needed for the subset of patients with atypical test results or not considered recovered.
Link Posted: 9/29/2022 8:25:18 AM EDT
[#1]
That one dude from Cali and the Pfizer funded doctor will be right along to crow about this.

“It wasn’t permanent damage so it doesn’t count” or something.
Link Posted: 9/29/2022 8:33:01 AM EDT
[#2]
Link Posted: 9/29/2022 9:33:12 AM EDT
[#3]
Discussion ForumsJump to Quoted PostQuote History
Quoted:
46% had depression and 54% had abnormal MRI's and that's considered recovered?

Ouch.
View Quote

Yeah, and a third were still not cleared for all physical activity.
Link Posted: 9/29/2022 9:59:50 AM EDT
[#4]
Discussion ForumsJump to Quoted PostQuote History
Quoted:
46% had depression and 54% had abnormal MRI's and that's considered recovered?

Ouch.
View Quote


All these studies will tell you a teenager who's on heart medication for the rest of his life with regular cardiac appointments has "recovered."
Link Posted: 9/29/2022 11:01:59 AM EDT
[#5]
Discussion ForumsJump to Quoted PostQuote History
Quoted:
That one dude from Cali and the Pfizer funded doctor will be right along to crow about this.

"It wasn't permanent damage so it doesn't count" or something.
View Quote
Their twisting of the facts would funny if it were not so sad.
Link Posted: 9/29/2022 11:12:34 AM EDT
[#6]
Link Posted: 9/29/2022 1:25:20 PM EDT
[#7]
Cousins teen boy is now taking blood pressure medication and still has a wierd heart beat.
Will ask about her other boys as I know they had some of the symptoms.
Close Join Our Mail List to Stay Up To Date! Win a FREE Membership!

Sign up for the ARFCOM weekly newsletter and be entered to win a free ARFCOM membership. One new winner* is announced every week!

You will receive an email every Friday morning featuring the latest chatter from the hottest topics, breaking news surrounding legislation, as well as exclusive deals only available to ARFCOM email subscribers.


By signing up you agree to our User Agreement. *Must have a registered ARFCOM account to win.
Top Top